Pricing Log in Create free account

Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs Neumora Therapeutics, Inc. (NMRA)

Corbus Pharmaceuticals Holdings, Inc. and Neumora Therapeutics, Inc. are both Biotechnology companies. Corbus Pharmaceuticals Holdings, Inc. and Neumora Therapeutics, Inc. are of similar size ($83.8M and $80.2M). Across the 9 metrics below, Corbus Pharmaceuticals Holdings, Inc. leads on 7 and Neumora Therapeutics, Inc. on 2.

Valuation

Metric CRBP NMRA Biotechnology median
P/E n/m n/m 8.50
P/S 56.97 n/m 9.71
P/B 0.86 1.95 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.07 n/m 0.64
EV/Sales (5.25) n/m 9.21
Earnings yield (136.95%) (261.70%) (33.15%)
Free cash flow yield (98.82%) (207.20%) (25.50%)

Profitability

Metric CRBP NMRA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (95.58%) (187.11%) (56.36%)
Return on assets (80.85%) (121.89%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRBP NMRA Biotechnology median
Revenue growth (TTM) (73.69%) — 6.02%
EPS growth (last fiscal year) (60.33%) 5.23% 30.26%
Revenue growth, 5-year CAGR (14.34%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CRBP NMRA Biotechnology median
Debt to equity 0.00 1.19 0.00
Current ratio 5.71 4.50 4.72
Net debt to EBITDA 1.90 0.53 0.96

Dividend

Metric CRBP NMRA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CRBP NMRA Biotechnology median
Market cap 83.75m 80.23m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack